These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 5117103)
1. Observations on the efficacy of L-dopa in progressive supranuclear palsy. Klawans HL; Ringel SP Eur Neurol; 1971; 5(2):115-29. PubMed ID: 5117103 [No Abstract] [Full Text] [Related]
2. Observations on the range of efficacy of L-dopa. Klawans HL Confin Neurol; 1971; 33(3):133-45. PubMed ID: 4940610 [No Abstract] [Full Text] [Related]
3. L-dopa. I. Br Med J; 1970 Nov; 4(5733):478-9. PubMed ID: 5481223 [No Abstract] [Full Text] [Related]
7. [Progressive supranuclear paralysis. A case with "apraxia of the eye opening" and favorable response to treatment with L-dopa]. Dehaene I; Bogaerts M Acta Neurol Belg; 1971; 71(2):141-5. PubMed ID: 5000585 [No Abstract] [Full Text] [Related]
8. Modification by L-dopa of a case of progressive supranuclear palsy. With evidence of defective cerebral dopamine metabolism. Mendell JR; Engel WK; Chase TN Lancet; 1970 Mar; 1(7647):593-4. PubMed ID: 4190545 [No Abstract] [Full Text] [Related]
9. L-dopa for progressive supranuclear palsy. De Renzi E; Vignolo LA Lancet; 1969 Dec; 2(7634):1360. PubMed ID: 4188119 [No Abstract] [Full Text] [Related]
10. The treatment of progressive supranuclear palsy with L-dopa. Donaldson IM Aust N Z J Med; 1973 Aug; 3(4):413-6. PubMed ID: 4519129 [No Abstract] [Full Text] [Related]
11. Progressive external ophthalmoplegia with Parkinsonism and Dementia. Treatment with L-dopa. Report of an autopsied case. Rajput AH; Chornell G; Rozdilsky B Can J Ophthalmol; 1972 Jul; 7(3):368-74. PubMed ID: 5056570 [No Abstract] [Full Text] [Related]
12. L-dopa for progressive supranuclear palsy. Gross M Lancet; 1969 Dec; 2(7634):1359-60. PubMed ID: 4188118 [No Abstract] [Full Text] [Related]
14. L-dopa for progressive supranuclear palsy. Jenkins R Lancet; 1969 Oct; 2(7623):742. PubMed ID: 4186183 [No Abstract] [Full Text] [Related]
15. Parkinsonism-dementia of Guam: treatment with L-dopa. Schnur JA; Chase TN; Brody JA Neurology; 1971 Dec; 21(12):1236-42. PubMed ID: 4257247 [No Abstract] [Full Text] [Related]
16. Sensitivity studies of L-dopa metabolites in reserpinized rats and their clinical significance. Ericsson AD; Wertman BG Neurology; 1971 Nov; 21(11):1129-33. PubMed ID: 5166218 [No Abstract] [Full Text] [Related]
17. [Considerations on hyperkinesis caused by L-dopa: significance of the biochemical deficit and anatomical deficit]. Pinelli P Arch Psicol Neurol Psichiatr; 1970; 31(5):405-16. PubMed ID: 5502810 [No Abstract] [Full Text] [Related]
18. [Effect of L-DOPA on the akinesis in Parkinson's syndrome]. Bischoff A Schweiz Med Wochenschr; 1967 Sep; 97(35):1158-9. PubMed ID: 5593650 [No Abstract] [Full Text] [Related]